Zomedica Shares Outstanding History (ZOMDF)
Zomedica reported 979.9M shares outstanding at the end of fiscal 2025.
View full Zomedica company overviewZomedica annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 979.9M | 0 | 0.00% |
| 2024 | 2024-12-31 | 979.9M | 0 | 0.00% |
| 2023 | 2023-12-31 | 979.9M | 0 | 0.00% |
| 2022 | 2022-12-31 | 979.9M | 50,000 | +0.01% |
| 2021 | 2021-12-31 | 979.9M | 337.9M | +52.62% |
| 2020 | 2020-12-31 | 642.0M | 534.0M | +494.27% |
| 2019 | 2019-12-31 | 108.0M | 10.4M | +10.70% |
| 2018 | 2018-12-31 | 97.6M | 7.4M | +8.17% |
| 2017 | 2017-12-31 | 90.2M | 6.3M | +7.46% |
| 2016 | 2016-12-31 | 84.0M | — | — |
Zomedica quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 979.9M | 0 | 0.00% |
| Q1 2026 | 2026-03-31 | 979.9M | 0 | 0.00% |
| Q4 2025 | 2025-12-31 | 979.9M | 0 | 0.00% |
| Q3 2025 | 2025-09-30 | 979.9M | 0 | 0.00% |
| Q2 2025 | 2025-06-30 | 979.9M | 0 | 0.00% |
| Q1 2025 | 2025-03-31 | 979.9M | 0 | 0.00% |
| Q4 2024 | 2024-12-31 | 979.9M | 0 | 0.00% |
| Q3 2024 | 2024-09-30 | 979.9M | 0 | 0.00% |
| Q2 2024 | 2024-06-30 | 979.9M | 0 | 0.00% |
| Q1 2024 | 2024-03-31 | 979.9M | 0 | 0.00% |
| Q4 2023 | 2023-12-31 | 979.9M | 0 | 0.00% |
| Q3 2023 | 2023-09-30 | 979.9M | 0 | 0.00% |
| Q2 2023 | 2023-06-30 | 979.9M | 50,000 | +0.01% |
| Q1 2023 | 2023-03-31 | 979.9M | 50,000 | +0.01% |
| Q4 2022 | 2022-12-31 | 979.9M | 50,000 | +0.01% |
| Q3 2022 | 2022-09-30 | 979.9M | 211,500 | +0.02% |
| Q2 2022 | 2022-06-30 | 979.9M | 1.9M | +0.20% |
| Q1 2022 | 2022-03-31 | 979.9M | 7.8M | +0.80% |
| Q4 2021 | 2021-12-31 | 979.9M | 337.9M | +52.62% |
| Q3 2021 | 2021-09-30 | 979.7M | 415.7M | +73.70% |
| Q2 2021 | 2021-06-30 | 978.0M | 616.9M | +170.87% |
| Q1 2021 | 2021-03-31 | 972.1M | 843.2M | +654.31% |
| Q4 2020 | 2020-12-31 | 642.0M | 534.0M | +494.27% |
| Q3 2020 | 2020-09-30 | 564.1M | 456.0M | +422.08% |
| Q2 2020 | 2020-06-30 | 361.0M | 253.0M | +234.18% |
| Q1 2020 | 2020-03-31 | 128.9M | 20.8M | +19.28% |
| Q4 2019 | 2019-12-31 | 108.0M | 10.4M | +10.70% |
| Q3 2019 | 2019-09-30 | 108.0M | 13.4M | +14.21% |
| Q2 2019 | 2019-06-30 | 108.0M | 13.5M | +14.31% |
| Q1 2019 | 2019-03-31 | 108.0M | 16.2M | +17.62% |
| Q4 2018 | 2018-12-31 | 97.6M | 7.4M | +8.17% |
| Q3 2018 | 2018-09-30 | 94.6M | 10.6M | +12.66% |
| Q2 2018 | 2018-06-30 | 94.5M | — | — |
| Q1 2018 | 2018-03-31 | 91.9M | — | — |
| Q4 2017 | 2017-12-31 | 90.2M | — | — |
| Q4 2016 | 2016-12-31 | 84.0M | — | — |
Zomedica shares outstanding trends
Over the last five reported fiscal years, Zomedica's shares outstanding moved from 642.0M to 979.9M, a change of 337.9M. The latest reported quarter, Q2 2026, shows 979.9M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zomedica filings at SEC.gov ↗